Quantum-Si announces 20% workforce cuts; Q2 revenue falls 42% as Proteus launch delayed

Quantum-Si

13/08/2026 21:23

Overview
US proteomics tech firm's Q2 revenue fell yr/yr during transition to new Proteus platform
Company delays anticipated Proteus launch to Q2 2027 to complete additional design cycle
Company cuts workforce by 20% and expects cash runway to extend into Q4 2028

Outlook
Quantum-Si updates anticipated Proteus commercial launch to Q2 2027
Company expects 2026 revenue of about $1.0 mln, adjusted operating expenses of $98.0 mln or less
Cost-reduction actions expected to extend cash runway into Q4 2028

Result Drivers
PLATFORM TRANSITION - Revenue decline attributed to lower instrument demand and customer migration during transition from Platinum to anticipated Proteus platform
COST REDUCTION - Operating expenses decreased due to cost-management actions, including a 20% workforce reduction
PROTEUS DEVELOPMENT - Continued investment in Proteus development and commercialization readiness impacted spending levels

Company press release: ID:nGNXbMgCLT

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$344,000
 
Q2 Loss Per Share attributable to common stockholders
 
$0.11
 
Q2 Net Loss
 
$23.53 mln
 
Q2 Operating Expenses
 
$25.80 mln
 
Q2 Operating Loss
 
$25.63 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for Quantum-Si Inc is $1.75, about 109% above its August 12 closing price of $0.84

Reuters Recommended Reads
Aug 11 - Seer Q2 revenue falls 23% as funding slows
Aug 11 - 908 Devices Q2 revenue beats on increased VipIR sales
Aug 12 - Bio-Techne beats revenue estimates on research, diagnostics demand uptick

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)